Inventor · disambiguated record
Colin Zhang
Also filed as: ZHANG COLIN
44 granted patents·13 pending applications·793 citations·filing 2005–2024
98Inventor score
Top patents by PatentIndex Score
57 records- 0199US7767675B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2007·Granted Aug 3, 2010·85 cites·85 claims
- 0298US11053246B2Substituted tricyclic compounds as FGFR inhibitorsINCYTE CORP·Filed 2020·Granted Jul 6, 2021·23 cites·10 claims
- 0398US10813930B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2019·Granted Oct 27, 2020·27 cites·42 claims
- 0498US10213427B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2016·Granted Feb 26, 2019·34 cites·39 claims
- 0598US10131667B2Substituted tricyclic compounds as FGFR inhibitorsINCYTE CORP·Filed 2017·Granted Nov 20, 2018·35 cites·16 claims
- 0698US9758523B2Triazolopyridines and triazolopyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2015·Granted Sep 12, 2017·21 cites·14 claims
- 0798US9695167B2Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2015·Granted Jul 4, 2017·33 cites·41 claims
- 0898US9611267B2Substituted tricyclic compounds as FGFR inhibitorsINCYTE CORP·Filed 2013·Granted Apr 4, 2017·54 cites·4 claims
- 0997US11840534B2Substituted tricyclic compounds as FGFR inhibitorsINCYTE CORP·Filed 2021·Granted Dec 12, 2023·4 cites·15 claims
- 1097US10138249B2Triazolopyridines and triazolopyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2017·Granted Nov 27, 2018·15 cites·21 claims
- 1197US9533954B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3INCYTE CORP·Filed 2014·Granted Jan 3, 2017·42 cites·26 claims
- 1297US8754114B2Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3YAO WENQING·Filed 2011·Granted Jun 17, 2014·49 cites·26 claims
- 1397US8461330B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsZHUO JINCONG·Filed 2010·Granted Jun 11, 2013·40 cites·25 claims
- 1496US7776874B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2008·Granted Aug 17, 2010·27 cites·24 claims
- 1596US7304081B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2005·Granted Dec 4, 2007·42 cites·25 claims
- 1695US9944645B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE HOLDINGS CORP·Filed 2016·Granted Apr 17, 2018·15 cites·15 claims
- 1795US9695168B2Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2015·Granted Jul 4, 2017·27 cites·63 claims
- 1895US9695180B2Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2015·Granted Jul 4, 2017·24 cites·53 claims
- 1995US8058288B2Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2010·Granted Nov 15, 2011·22 cites·35 claims
- 2094US10968221B2Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2019·Granted Apr 6, 2021·6 cites·10 claims
- 2194US10125133B2Substituted [1,2,4]triazolo[1,5-a]pyridines and substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2017·Granted Nov 13, 2018·15 cites·46 claims
- 2294US10112950B2Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2017·Granted Oct 30, 2018·15 cites·58 claims
- 2394US9126927B2Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2011·Granted Sep 8, 2015·20 cites·33 claims
- 2494US7683060B2Triazolotriazines as kinase inhibitorsINCYTE CORP·Filed 2007·Granted Mar 23, 2010·25 cites·152 claims
- 2593US10640503B2Imidazopyridines and imidazopyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2018·Granted May 5, 2020·7 cites·66 claims
- 2693US8071624B2N-substituted piperidines and their use as pharmaceuticalsYAO WENQING·Filed 2005·Granted Dec 6, 2011·26 cites·43 claims
- 2792US10738052B2Imidazotriaines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2018·Granted Aug 11, 2020·3 cites·18 claims
- 2892US7687665B22-methylprop anamides and their use as pharmaceuticalsINCYTE CORP·Filed 2005·Granted Mar 30, 2010·24 cites·28 claims
- 2990US10556908B2Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2018·Granted Feb 11, 2020·8 cites·37 claims
- 3089US9957229B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2017·Granted May 1, 2018·4 cites·6 claims
- 3189US2025223291A1Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3285US8143251B2Triazolotriazines as kinase inhibitorsZHUO JINCONG·Filed 2011·Granted Mar 27, 2012·7 cites·17 claims
- 3384US7915408B2Triazolotriazines as kinase inhibitorsINCYTE CORP·Filed 2010·Granted Mar 29, 2011·6 cites·29 claims
- 3482US12084449B2Imidazotriazines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2022·Granted Sep 10, 2024·0 cites·1 claims
- 3579US10047086B2Imidazopyridines and imidazopyrazines as LSD1 inhibitorsINCYTE CORP·Filed 2017·Granted Aug 14, 2018·2 cites·65 claims
- 3678US9006260B2Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1YAO WENQING·Filed 2012·Granted Apr 14, 2015·2 cites·12 claims
- 3777US8110581B2Lactam compounds and their use as pharmaceuticalsYAO WENQING·Filed 2008·Granted Feb 7, 2012·2 cites·22 claims
- 3876US8278318B2Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1YAO WENQING·Filed 2008·Granted Oct 2, 2012·1 cites·6 claims
- 3974US11261191B2Imidazotriaines and imidazopyrimidines as kinase inhibitorsINCYTE CORP·Filed 2020·Granted Mar 1, 2022·0 cites·21 claims
- 4068US2019127376A1Substituted tricyclic compounds as fgfr inhibitorsINCYTE CORP·Filed 2018·Application pending·0 cites
- 4167US8436008B2Substituted heterocyclic compoundsZHANG COLIN·Filed 2009·Granted May 7, 2013·1 cites·5 claims
- 4264US2007179142A1Amido compounds and their use as pharmaceuticalsYAO WENQING·Filed 2007·Application pending·0 cites
- 4363US2019152976A1Triazolopyridines and triazolopyrazines as lsd1 inhibitorsINCYTE CORP·Filed 2018·Application pending·0 cites
- 4463US2013324515A1Imidazotriazines and imidazopyrimidines as kinase inhibitorsZHUO JINCONG·Filed 2013·Application pending·0 cites
- 4562US9670154B2Amido compounds and their use as pharmaceuticalsINCYTE CORP·Filed 2015·Granted Jun 6, 2017·0 cites·3 claims
- 4662US2019119272A1Triazolopyridines and triazolopyrazines as lsd1 inhibitorsINCYTE CORP·Filed 2018·Application pending·0 cites
- 4760US9873698B2Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1INCYTE CORP·Filed 2016·Granted Jan 23, 2018·0 cites·5 claims
- 4855US9371323B2Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1INCYTE CORP·Filed 2015·Granted Jun 21, 2016·0 cites·12 claims
- 4949US8563570B2Lactam compounds and their use as pharmaceuticalsYAO WENQING·Filed 2012·Granted Oct 22, 2013·0 cites·31 claims
- 5049US8288417B2N-substituted piperidines and their use as pharmaceuticalsYAO WENQING·Filed 2011·Granted Oct 16, 2012·0 cites·21 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Colin Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →